Related references
Note: Only part of the references are listed.A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer
Svenja Lier et al.
BIOORGANIC CHEMISTRY (2022)
Development of MDM2 degraders based on ligands derived from Ugi reactions: Lessons and discoveries
Bo Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery of CRBN E3 Ligase Modulator CC-92480 for the Treatment of Relapsed and Refractory Multiple Myeloma
Joshua D. Hansen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Targeted protein degradation: current and future challenges
Alexander Hanzl et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2020)
CC-90009, a novel cereblon E3 ligase modulator targets acute myeloid leukemia blasts and leukemia stem cells
Christine Surka et al.
BLOOD (2020)
Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras
Akshay D. Takwale et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Development of targeted protein degradation therapeutics
Philip P. Chamberlain et al.
NATURE CHEMICAL BIOLOGY (2019)
A Novel Cereblon E3 Ligase Modulator Eradicates Acute Myeloid Leukemia Stem Cells through Degradation of Translation Termination Factor GSPT1
Liqing Jin et al.
BLOOD (2019)
A novel cereblon modulator for targeted protein degradation
Sung Ah Kim et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
A First-in-Human Study of Novel Cereblon Modulator Avadomide (CC-122) in Advanced Malignancies
Drew W. Rasco et al.
CLINICAL CANCER RESEARCH (2019)
A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos
Mary E. Matyskiela et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Protein Degradation via CRL4CRBN Ubiquitin Ligase: Discovery and Structure-Activity Relationships of Novel Glutarimide Analogs That Promote Degradation of Aiolos and/or GSPT1
Joshua D. Hansen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Induced protein degradation: an emerging drug discovery paradigm
Ashton C. Lai et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Small-Molecule PROTACS: New Approaches to Protein Degradation
Momar Toure et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase
Mary E. Matyskiela et al.
NATURE (2016)
CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL
Patrick R. Hagner et al.
BLOOD (2015)
The ins and outs of selective kinase inhibitor development
Susanne Mueller et al.
NATURE CHEMICAL BIOLOGY (2015)
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Jan Kroenke et al.
SCIENCE (2014)
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
Gang Lu et al.
SCIENCE (2014)
Cryoelectron Microscopic Structures of Eukaryotic Translation Termination Complexes Containing eRF1-eRF3 or eRF1-ABCE1
Anne Preis et al.
CELL REPORTS (2014)
Identification of a Primary Target of Thalidomide Teratogenicity
Takumi Ito et al.
SCIENCE (2010)
Design, synthesis and identification of novel colchicine-derived immunosuppressant
Dong-Jo Chang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Structural insights into eRF3 and stop codon recognition by eRF1
Zhihong Cheng et al.
GENES & DEVELOPMENT (2009)
Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomics
Ashley R. Schneekloth et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
CUL4-DDB1 ubiquitin ligase interacts with multiple WD40-repeat proteins and regulates histone methylation
Leigh Ann Higa et al.
NATURE CELL BIOLOGY (2006)
DDB1 functions as a linker to recruit receptor WD40 proteins to CUL4-ROC1 ubiquitin ligases
Yizhou Joseph He et al.
GENES & DEVELOPMENT (2006)
A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1
Jianping Jin et al.
MOLECULAR CELL (2006)
Share Paper
